Tea planter Vishal Mahindra was twice diagnosed with non-Hodgkin's lymphoma, a type of blood cancer that develops in the ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Approval follows results from the Phase III ECHO trial, which demonstrated that Calquence plus chemotherapy reduced the risk ...

AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

Given the suspicion of mediastinal lymphoma, a mediastinoscopy with lymph node biopsy ... It was decided to re-evaluate the diagnosis of SLE. The patient denied skin rashes, psoriatic lesions, Raynaud ...

The widow of an Air Force missileer who died of non-Hodgkin lymphoma has finally secured Department of Veterans Affairs benefits connected to her late husband's passing, a major achievement as ...

B-cell lymphoma accounts for approximately 85 percent of non-Hodgkin lymphoma (NHL) cases, which is one of the most common cancers in the US. 3 "Accurately differentiating lymphoma from an ...

B-cell lymphoma accounts for approximately 85 percent of non-Hodgkin lymphoma (NHL) cases, which is one of the most common cancers in the US. 3 "Accurately differentiating lymphoma from an infection ...

Investing.com - The U.S. services sector accelerated in September, but employment slowed significantly, consistent with an easing labor market. The Institute for Supply Management said on Thursday ...